Patent · US Active

Klebsiella pneumoniae capsule polysaccharide vaccines

US11097000B2 · kind B2 · utility

0Cited by
0References
26Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 3, 2017
Grant dateAug 24, 2021
Priority date
Expiry dateOct 3, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/70
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides various immunogens comprising a repeat unit of saccharide of Klebsiella pneumoniae CPS, which has a formula selected from the group consisting of Formulae (I) to (VI) as described herein. Also provided are vaccines including one or more immunogens selected from Formula (I) to (VI) and methods of eliciting an immune response against a Klebsiella pneumoniae and preventing infection of Klebsiella pneumoniae by using an immunogen of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.